Special Issue on Drug Therapy and Disease Control
Drug
Therapy and Disease Control is a multidisciplinary field focused on the
development, evaluation, and clinical application of pharmacological treatments
to prevent, manage, and cure diseases. It encompasses the study of drug
mechanisms, efficacy, safety, dosage optimization, and therapeutic strategies
across acute and chronic conditions. The field integrates insights from
pharmacology, clinical medicine, molecular biology, and public health to ensure
effective disease control at both individual and population levels. By
emphasizing evidence-based practice, personalized medicine, and innovative drug
development, Drug Therapy and Disease Control aims to improve patient outcomes,
reduce disease burden, and enhance overall health management.
In this special issue, we intend to invite
front-line researchers and authors to submit original research and review
articles on exploring Drug Therapy and Disease Control. Potential topics include, but are not limited to:
-
Antimicrobial resistance management
-
Cancer pharmacotherapy
-
Cardiovascular drug therapy
-
Chronic disease management
-
Clinical drug trials
-
Drug delivery systems and formulation
-
Drug safety and adverse effects
-
Evidence-based medicine in drug therapy
-
Geriatric pharmacotherapy
-
Infectious disease therapy
-
Neurological and psychiatric drug management
-
Pediatric pharmacotherapy
-
Personalized medicine and pharmacogenomics
-
Pharmacology and pharmacokinetics
-
Public health and disease prevention
strategies
-
Vaccine development and immunotherapy
Authors should read over the journal’s For Authors carefully before submission. Prospective authors should submit an electronic
copy of their complete manuscript through the journal’s Paper Submission
System.
Please kindly specify the “Special Issue”
under your manuscript title. The research field “Special Issue - Drug
Therapy and Disease Control” should be selected during your submission.
pecial Issue Timetable:
|
Submission Deadline
|
May 18th, 2026
|
|
Publication Date
|
July 2026
|
Guest Editor:
Dr.
Marjan Dzeparoski
Associate
Professor, Faculty for Medical Sciences, Stip, Macedonia
Member,
Pharmaceutical Chamber of R. Macedonia, Athens Institute for Education &
Research and European Federation of Biotechnology (EFB), Macedonia
For
further questions or inquiries, please contact Editorial Assistant at [email protected].